VitaDX will be present at EAU24
3 April 2024 -
VitaDX selected by Pfizer and WILCO to be part of the new #PfizerHealthcareHub France promo
16 January 2024 -
Avero Diagnostics and VitaDX announce the signing of a strategic partnership for the distribution in the United States of VisioCyt® Bladder, a diagnostic test for bladder cancer
18 December 2023 -
CFU et Carrefour Pathologie
VitaDX at CFU and Carrefour Pathologie!
17 November 2023 -
Launch of the participatory financing campaign!
14 November 2023 -

It's official: the Sowefund crowdfunding campaign is now public and open to all!

VitaDX wins France2030's "Medical Imaging" call for projects!
18 October 2023 -
JT 20h TF1
VisioCyt® on TF1!
8 June 2023 -

A big thank you to the TF1 Group for this report broadcast on June 07, 2023 on the 8:00 pm news, showing the benefits of Artificial Intelligence…

Come and meet us !
2 January 2023 -

We will be present at several events in 2023. If you'd like to find out more about us and VisioCyt, our first innovative solution for bladder…

Mltidisciplinary Masterclass dedicated to prostate and bladder cancers
8 July 2022 -

Multidisciplinary Masterclass organized by the American Hospital in Paris, MEDIPATH and Ibex Medical Analytics dedicated to prostate and bladder…